Literature DB >> 23748896

Determination of tolerable fatty acids and cholera toxin concentrations using human intestinal epithelial cells and BALB/c mouse macrophages.

Farshad Tamari1, Joanna Tychowski, Laura Lorentzen.   

Abstract

The positive role of fatty acids in the prevention and alleviation of non-human and human diseases have been and continue to be extensively documented. These roles include influences on infectious and non-infectious diseases including prevention of inflammation as well as mucosal immunity to infectious diseases. Cholera is an acute intestinal illness caused by the bacterium Vibrio cholerae. It occurs in developing nations and if left untreated, can result in death. While vaccines for cholera exist, they are not always effective and other preventative methods are needed. We set out to determine tolerable concentrations of three fatty acids (oleic, linoleic and linolenic acids) and cholera toxin using mouse BALB/C macrophages and human intestinal epithelial cells, respectively. We solubilized the above fatty acids and used cell proliferation assays to determine the concentration ranges and specific concentrations of the fatty acids that are not detrimental to human intestinal epithelial cell viability. We solubilized cholera toxin and used it in an assay to determine the concentration ranges and specific concentrations of cholera toxin that do not statistically decrease cell viability in BALB/C macrophages. We found the optimum fatty acid concentrations to be between 1-5 ng/μl, and that for cholera toxin to be < 30 ng per treatment. This data may aid future studies that aim to find a protective mucosal role for fatty acids in prevention or alleviation of cholera infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23748896      PMCID: PMC3734972          DOI: 10.3791/50491

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells.

Authors:  John D Palombo; Aniruddha Ganguly; Bruce R Bistrian; Michael P Menard
Journal:  Cancer Lett       Date:  2002-03-28       Impact factor: 8.679

2.  Antithromboxane activity of dietary alpha-linolenic acid: a pilot study.

Authors:  A Ferretti; V P Flanagan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1996-06       Impact factor: 4.006

3.  Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.

Authors:  W B Rizzo; M W Phillips; A L Dammann; R T Leshner; S S Jennings; J Avigan; V K Proud
Journal:  Ann Neurol       Date:  1987-03       Impact factor: 10.422

4.  Effect of fatty acids and cholesterol present in bile on expression of virulence factors and motility of Vibrio cholerae.

Authors:  Arpita Chatterjee; Pradeep K Dutta; Rukhsana Chowdhury
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

5.  Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism.

Authors:  Y Yu; P H Correll; J P Vanden Heuvel
Journal:  Biochim Biophys Acta       Date:  2002-04-15

6.  Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis.

Authors:  Elliot D Rosenstein; Laura J Kushner; Neil Kramer; Gregory Kazandjian
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-03       Impact factor: 4.006

7.  Oleic acid: its effects on stratum corneum in relation to (trans)dermal drug delivery.

Authors:  M L Francoeur; G M Golden; R O Potts
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

8.  X-ray diffraction and spectroscopic studies of oleic acid-sodium oleate.

Authors:  P Tandon; S Raudenkolb; R H Neubert; W Rettig; S Wartewig
Journal:  Chem Phys Lipids       Date:  2001-01       Impact factor: 3.329

9.  Chemical composition and oxidative stability of flax, safflower and poppy seed and seed oils.

Authors:  Berrin Bozan; Feral Temelli
Journal:  Bioresour Technol       Date:  2008-01-15       Impact factor: 9.642

10.  Fatty acids and obesity.

Authors:  M Bermúdez Menéndez de la Granda; A J Sinclair
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.